ロード中...
Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use
BACKGROUND: Vilazodone is the latest approved antidepressant available in the United States. Its dual mechanism of action combines the inhibition of serotonin transporters while simultaneously partially agonizing serotonin-1a (5-HT1A) receptors. This combined activity results in serotonin facilitati...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3333788/ https://ncbi.nlm.nih.gov/pubmed/22536068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S20683 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|